David Natan - Jan 2, 2025 Form 4 Insider Report for Cyclacel Pharmaceuticals, Inc. (CYCC)

Role
Director
Signature
/s/ David Natan
Stock symbol
CYCC
Transactions as of
Jan 2, 2025
Transactions value $
$0
Form type
4
Date filed
1/7/2025, 07:07 PM
Previous filing
Oct 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYCC Common Stock Award +100K 100K Jan 2, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of restricted stock issued pursuant to a Director Agreement dated as of January 2, 2025 by and between Cyclacel Pharmaceuticals, Inc. and David Natan.